Paper Details

  1. Home
  2. Paper Details

Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1 [ISRCTN84121379].

Author: KesselsAlfons H F, Stomp-van den BergSuzanne G M, WeberWim E J, van de VusseAnton C

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Complex Regional Pain Syndrome type 1 (CRPS I) is a painful condition that affects a limb and can be very disabling. Pain that is caused by nerve damage is a common symptom and difficult to treat. Gabapentin is a medication used for seizures that has also been found to reduce pain related to nerve damage. This study investigated the effectiveness of gabapentin in treating pain in people with CRPS I.
Paper Details　
Original Abstract of the Article :
Complex Regional Pain Syndrome type one (CRPS I) or formerly Reflex Sympathetic Dystrophy (RSD) is a disabling syndrome, in which a painful limb is accompanied by varying symptoms. Neuropathic pain is a prominent feature of CRPS I, and is often refractory to treatment. Since gabapentin is an anticon...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC523854/

データ提供：米国国立医学図書館（NLM）

Seeking Relief in the Desert of Chronic Pain: A Trial of Gabapentin for Complex Regional Pain Syndrome

Complex regional pain syndrome (CRPS) is a debilitating condition characterized by severe, persistent pain in a limb. This study investigates the efficacy of gabapentin, an anticonvulsant known for its analgesic effects, in treating pain associated with CRPS.

The researchers conducted a randomized controlled trial to assess the effectiveness of gabapentin in patients with CRPS. The findings suggest that gabapentin may offer some relief from pain in individuals with CRPS, providing a potential avenue for managing this challenging condition. It’s like finding a well of relief in the midst of a scorching desert – a source of comfort and respite from the relentless pain.

A Ray of Hope in the Desert: Gabapentin for CRPS

The study’s results provide a glimmer of hope for individuals suffering from CRPS, suggesting that gabapentin may offer some relief from the chronic pain associated with this condition. This is like finding a path to a hidden oasis – a place of comfort and healing in the vast desert of chronic pain.

Navigating the Desert of Chronic Pain

This research highlights the importance of exploring various treatment options for CRPS, as finding the right path to pain relief can be challenging. It’s like navigating a desert – searching for the best resources and strategies to find relief from the relentless heat and discomfort. By understanding the potential of medications like gabapentin, we can help individuals with CRPS find a path toward a more comfortable and fulfilling life.

Dr. Camel's Conclusion

This study provides valuable insights into the potential of gabapentin for managing pain in patients with complex regional pain syndrome. It’s like discovering a hidden wellspring of relief in the vast desert of chronic pain, offering hope for a more comfortable and fulfilling life for individuals with this challenging condition.

Date :
  1. Date Completed 2005-07-05
  2. Date Revised 2018-11-30
Further Info :

Pubmed ID

15453912

DOI: Digital Object Identifier

PMC523854

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.